BlackRock, Inc. and Bank of America Corporation for instance, reported a passive stake in MTP stock a few weeks ago. But this week, there’s more than just institutions looking at Midatech and for good reason. On July 21 the company announced a research collaboration for its Q-Sphera platform with a European affiliate of a global pharmaceutical company. Midatech will deploy its in-house expertise and proprietary drug delivery platforms towards assets nominated by the pharmaceutical company.

Unlock the rest of this article with a 14 day trial

or Unlock with your email

Already have an account?
Login here